Thought Leadership

Manatt Health: Health AI Policy Tracker

The purpose of this tracker is to identify key federal and state health AI policy activity since July 2024 and summarize laws relevant to the use of AI in health care that were passed between January and October. 

View More

New Guidance on Use of Artificial Intelligence-Based Tools in Practice Before USPTO

The United States Patent and Trademark Office (USPTO) published guidance on the use of artificial intelligence-based tools in patent practice to inform practitioners of important issues when using Artificial Intelligence (AI) in matters before the Patent Office.

View More

Colorado Enacts Law Regulating “High-Risk” AI: Here’s What You Should Know

On May 17, Colorado Governor Jared Polis signed into law Colorado Senate Bill 2-205 (SB 205), also known as the Colorado Artificial Intelligence Act—making Colorado the second state to enact comprehensive legislation on artificial intelligence (AI), and the first to...

View More

CO Enacts “High-Risk” AI Law Regulating Deployers and Developers, Including Health Care Stakeholders

On Friday, May 17, Colorado Governor Jared Polis, with noted reservations, signed into law SB205, a consumer protection law which imposes significant requirements on developers and deployers of “high risk&rdquo...

View More

Manatt Launches Health AI Policy Tracker

Manatt’s new Health AI Policy Tracker identifies key federal and state AI policy activity most relevant to the health care industry.

View More

HIPAA Enforcer Updates Guidelines on Online Tracking Amid Calls for Clarity: Key Takeaways

On March 18, 2024, the Office for Civil Rights (OCR) at the U.S. Department of Health and Human Services (HHS) updated its December 2022 guidance for HIPAA-regulated entities regarding the use of online tracking technologies on websites and apps.

View More

There’s Nothing Weak About the SEC’s “Weakened” Climate Disclosure Mandate

The Securities and Exchange Commission (SEC) released its long-awaited climate disclosure mandate for publicly traded companies (Final Rule).

View More

The FDA and the Future of AI Oversight

In January 2024, the U.S. Government Accountability Office (GAO) issued a report highlighting current obstacles to the U.S. Food and Drug Administration’s (FDA) timely and effective regulation of artificial intelligence (AI) and machine learning (ML) in medical devices and other emerging health care technologies (GAO...

View More

Advancing Women’s Reproductive Health Access: Medicaid Should Be a Part of Your Growth Strategy

Medicaid is a critical source of health care coverage for women in their childbearing years, covering 1 in 5, or 13 million, women of reproductive age.

View More

Getting the Most from Transformative Technologies

The second webinar in our innovation series will discuss how to get the most out of transformative technological change in healthcare.

View More
Services








Key Topics




Clear